Area of research
Pulmonary and Respiratory Medicine · Reproductive Medicine
Research interest
Research interests include Sarcoma Diagnosis and Treatment, Ovarian cancer diagnosis and treatment, Chromatin Remodeling and Cancer, and Neuroblastoma Research and Treatments.
Nirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors
Tazemetostat in advanced epithelioid sarcoma with loss of INI1/SMARCB1: an international, open-label, phase 2 basket study
Results of a Randomized, Double-Blinded, Placebo-Controlled, Phase 2.5 Study of Saracatinib (AZD0530), in Patients with Recurrent Osteosarcoma Localized to the Lung
Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
Clinicopathologic Features of a Series of Primary Renal CIC-rearranged Sarcomas With Comprehensive Molecular Analysis
Pediatric Anaplastic Embryonal Rhabdomyosarcoma: Targeted Therapy Guided by Genetic Analysis and a Patient-Derived Xenograft Study
Successful Treatment of Recurrent Primitive Myxoid Mesenchymal Tumor of Infancy With<i>BCOR</i>Internal Tandem Duplication
Whole exome sequencing identified sixty-five coding mutations in four neuroblastoma tumors
In vivo expansion and activation of γδ T cells as immunotherapy for refractory neuroblastoma
Gorham-Stout Disease Successfully Treated With Sirolimus and Zoledronic Acid Therapy
Zoledronic acid in metastatic osteosarcoma: encouraging progression free survival in four consecutive patients
Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4
GLI inhibitor GANT-61 diminishes embryonal and alveolar rhabdomyosarcoma growth by inhibiting Shh/AKT-mTOR axis
Interim Analysis of a Phase 1 Study of the Antibody-Drug Conjugate SGN-CD19A in Relapsed or Refractory B-Lineage Acute Leukemia and Highly Aggressive Lymphoma
Treatment of Infantile Hemangiomas with Sirolimus in a Patient with <scp>PHACE</scp> Syndrome
Rapamycin targeting mTOR and hedgehog signaling pathways blocks human rhabdomyosarcoma growth in xenograft murine model
Successful Treatment of Preadolescents With Small Cell Carcinoma of the Ovary Hypercalcemic Type
A randomized, double-blinded, placebo-controlled, multi-institutional, cross-over, phase II.5 study of saracatinib (AZD0530), a selective Src kinase inhibitor, in patients with recurrent osteosarcoma localized to the lung.
CD133 marks a myogenically primitive subpopulation in rhabdomyosarcoma cell lines that are relatively chemoresistant but sensitive to mutant HSV